Search company, investor...
eFFECTOR Therapeutics company logo

eFFECTOR Therapeutics

effector.com

Founded Year

2012

Stage

Acq - Pending | Acquired

Total Raised

$139.6M

About eFFECTOR Therapeutics

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR's approach provides a real opportunity to bring new medicines to patients in need.

Headquarters Location

11180 Roselle Street Suite A

San Diego, California, 92121,

United States

858-442-4861

Missing: eFFECTOR Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: eFFECTOR Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing eFFECTOR Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

eFFECTOR Therapeutics is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

838 items

eFFECTOR Therapeutics Patents

eFFECTOR Therapeutics has filed 33 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Gene expression
  • Experimental cancer drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/28/2020

9/13/2022

Gene expression, Molecular biology, RNA, Protein biosynthesis, Ribosomal proteins

Grant

Application Date

2/28/2020

Grant Date

9/13/2022

Title

Related Topics

Gene expression, Molecular biology, RNA, Protein biosynthesis, Ribosomal proteins

Status

Grant

eFFECTOR Therapeutics Frequently Asked Questions (FAQ)

  • When was eFFECTOR Therapeutics founded?

    eFFECTOR Therapeutics was founded in 2012.

  • Where is eFFECTOR Therapeutics's headquarters?

    eFFECTOR Therapeutics's headquarters is located at 11180 Roselle Street, San Diego.

  • What is eFFECTOR Therapeutics's latest funding round?

    eFFECTOR Therapeutics's latest funding round is Acq - Pending.

  • How much did eFFECTOR Therapeutics raise?

    eFFECTOR Therapeutics raised a total of $139.6M.

  • Who are the investors of eFFECTOR Therapeutics?

    Investors of eFFECTOR Therapeutics include Locust Walk Acquisition, Abingworth, Astellas Venture Management, Novartis Venture Funds, U.S. Venture Partners and 12 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.